Journal of Vaccines & Vaccination

Strengthening pipeline development through innovative licensing collaborations

2^nd International Conference on Vaccines and Vaccination

August 20-22, 2012 Hilton Chicago/Northbrook, USA

Gavin Zealey

Scientific Tracks Abstracts: J Vaccines Vaccin

Abstract:

C ollaborations, partnerships and licenses to new products and technologies are core to the Sanofi pasteur vaccine pipeline. There are many possible deal structures (acquisitions/options/licenses\fee-for-service) to accommodate the needs of a variety of partners. Critical issues for the establishment and success of partnerships will be described to strengthen pipelines through innovative licensing

Biography :

Dr Gavin Zealey is Senior Director, Corporate Development at Sanofi pasteur. Sanofi pasteur is the vaccines business of the pharmaceutical company Sanofi and is a world leader in human vaccines. Dr Zealey identifies opportunities for global licensing and acquisition of technologies used in the development of new products. He provides strategic and tactical evaluation of new business opportunities for vaccine product development, business partnerships, their technologies and alternatives to commercial relationships. He has negotiated many agreements, creating and managing commercial relationships. He has a Ph.D. an MBA from the Kellogg School of Management, is registered to practice before the Canadian and US Patent Offices and is a Certified Licensing Professional